Featured Posts
Inova Mount Vernon Hospital Breaks Ground on New $22.8M Emergency Department
MOUNT VERNON, VA – September 22, 2015 – To better meet the needs of residents across the community it serves, Inova Mount Vernon Hospital today broke ground on a new, $22.8 million, 22,500 square-foot emergency department. The new facility will be named the Veatch Family Emergency Department in recognition of lead donor and local entrepreneur Jeffrey…
Read MoreNew data suggests flu shots will improve in 2015, WJLA ABC 7, September 17, 2015
Inova’s Dr. Sujata Ambardar, infectious disease physician, spoke with WJLA ABC 7 about the importance of the flu vaccine in flu prevention.
Read MoreProstate Cancer Is the Second Most Common Cancer in American Men
Dr. Aragon-Ching serves as the Clinical Program Director of Genitourinary Cancers within the Inova Dwight and Martha Schar Cancer Institute. Schedule an appointment or learn more about Dr. Aragon-Ching. Prostate Cancer Awareness Month Prostate cancer is the most common cancer, apart from skin cancer, that occurs among American men. In 2015 alone, a projected 220,000…
Read MoreInova Launches Online Physician Reviews
Washington DC – September 8, 2015 – As part of Inova’s ongoing commitment to transparency and improvement, the health system today announced a new online resource for patients looking for the best available care: patient reviews of Inova Medical Group physicians. Inova is the first healthcare system in the Mid-Atlantic to make both star ratings…
Read MorePreventing Melanoma: Should You Drink More Coffee and Hold Off on the Viagra?
Suraj Venna, MD, is board certified in dermatology. He is the founding director of the Inova Melanoma and Skin Cancer Center. Dr. Venna specializes in detecting and treating skin cancer. Dr. Venna is also chair for the 2015 American Society of Clinical Oncology Melanoma Education Committee, the largest international meeting of oncologists. Read Dr. Venna’s…
Read MoreJimmy Carter’s Rare Cancer Diagnosis
Suraj Venna, MD, is board certified in dermatology. He is the founding director of the Inova Melanoma and Skin Cancer Center. Dr. Venna specializes in detecting and treating skin cancer. Dr. Venna is also chair for the 2015 American Society of Clinical Oncology Melanoma Education Committee, the largest international meeting of oncologists. Read Dr. Venna’s…
Read MoreThe Future of Personalized Health at Inova
John Deeken, MD, is board certified in medical oncology. He specializes in treating patients with head and neck cancer. He is especially interested in using genomics to personalize cancer treatments and in developing targeted therapies. Dr. Deeken serves as associate director for Clinical Research for the Inova Dwight and Martha Schar Cancer Institute. In addition,…
Read MoreSupplements: Proceed with Caution
Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. His specialty is managing gastrointestinal cancers. Dr. Cannon emphasizes personalized care for his patients and is interested in pharmacogenomics as well as using technology to improve patients’ access to care. Read Dr. Cannon’s profile. An employee once told me that she…
Read MorePharmacogenomics: Personalized Medicine in Action
Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. His specialty is managing gastrointestinal cancers. Dr. Cannon emphasizes personalized care for his patients and is interested in pharmacogenomics as well as using technology to improve patients’ access to care. Read Dr. Cannon’s profile. Many patients that are receiving chemotherapy ask…
Read MoreFolic Acid Fortification: Is it a Great Idea?
Kate Burdekin is a clinical research associate with Inova Dwight and Martha Schar Cancer Institute. She coordinates the administrative and regulatory aspects of clinical trials. Kate has a BS in neurobiology and physiology from University of Maryland. She is currently working to complete a master’s degree in public health with a concentration in epidemiology and biostatistics from University…
Read More